Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Martin

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Journal of Alzheimer'S Disease : JAD|April 8, 2014
Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controlsHanne Struyfs, José L Molinuevo, Jean-Jacques Martin, et al.
American Journal of Medical Genetics. Part A|January 8, 2005
Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 geneWim Wuyts, Edwin Reyniers, Chantal Ceuterick, et al.
Annals of the New York Academy of Sciences|September 18, 2009
A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophagesBoel De Paepe, Kim K Creus, Jean-Jacques Martin, et al.
Journal of Neurology|March 12, 2004
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patientsBart Van Everbroeck, Itte Dobbeleir, Michele De Waele, et al.
Neurochemistry International|June 16, 2009
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P)Karen Koopman, Nathalie Le Bastard, Jean-Jacques Martin, et al.
Neurobiology of Aging|January 20, 2009
Added diagnostic value of CSF biomarkers in differential dementia diagnosisNathalie Le Bastard, Jean-Jacques Martin, Eugeen Vanmechelen, et al.
Alzheimer'S Research & Therapy|February 27, 2015
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's diseaseYannick Vermeiren, Debby Van Dam, Tony Aerts, et al.
Neuromuscular Disorders : NMD|March 17, 2004
Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathiesBoel De Paepe, J Michael Schröder, Jean-Jacques Martin, et al.
Frontiers in Neurology|July 3, 2015
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia DiagnosisHanne Struyfs, Ellis Niemantsverdriet, Joery Goossens, et al.
Acta Neuropathologica|June 29, 2004
Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's diseaseBart Van Everbroeck, Itte Dobbeleir, Michèle De Waele, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Journal of Alzheimer'S Disease : JAD|April 8, 2014
Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controlsHanne Struyfs, José L Molinuevo, Jean-Jacques Martin, et al.
American Journal of Medical Genetics. Part A|January 8, 2005
Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 geneWim Wuyts, Edwin Reyniers, Chantal Ceuterick, et al.
Annals of the New York Academy of Sciences|September 18, 2009
A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophagesBoel De Paepe, Kim K Creus, Jean-Jacques Martin, et al.
Journal of Neurology|March 12, 2004
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patientsBart Van Everbroeck, Itte Dobbeleir, Michele De Waele, et al.
Neurochemistry International|June 16, 2009
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P)Karen Koopman, Nathalie Le Bastard, Jean-Jacques Martin, et al.
Neurobiology of Aging|January 20, 2009
Added diagnostic value of CSF biomarkers in differential dementia diagnosisNathalie Le Bastard, Jean-Jacques Martin, Eugeen Vanmechelen, et al.
Alzheimer'S Research & Therapy|February 27, 2015
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's diseaseYannick Vermeiren, Debby Van Dam, Tony Aerts, et al.
Neuromuscular Disorders : NMD|March 17, 2004
Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathiesBoel De Paepe, J Michael Schröder, Jean-Jacques Martin, et al.
Frontiers in Neurology|July 3, 2015
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia DiagnosisHanne Struyfs, Ellis Niemantsverdriet, Joery Goossens, et al.
Acta Neuropathologica|June 29, 2004
Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's diseaseBart Van Everbroeck, Itte Dobbeleir, Michèle De Waele, et al.
Pageof 11